BioAdaptives, Inc. (BDPT)
OTCMKTS
· Delayed Price · Currency is USD
0.0825
+0.0175 (26.85%)
May 14, 2025, 4:00 PM EDT
BioAdaptives Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | -98.19% | -55.65% | 66.31% | -13.15% | 21.13% | 64.35% | Upgrade
|
| Cost of Revenue | 0.08 | 0.09 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Gross Profit | -0.08 | -0.08 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Selling, General & Admin | 0.7 | 0.5 | 0.21 | 0.37 | 0.35 | 0.12 | Upgrade
|
| Operating Expenses | 0.7 | 0.51 | 0.24 | 0.43 | 0.65 | 0.26 | Upgrade
|
| Operating Income | -0.78 | -0.58 | -0.23 | -0.42 | -0.64 | -0.25 | Upgrade
|
| Interest Expense | -0.05 | -0.09 | -0.16 | -0.29 | -0.27 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.06 | -0.21 | -0.31 | -0.18 | -0.09 | -0.36 | Upgrade
|
| EBT Excluding Unusual Items | -0.77 | -0.88 | -0.7 | -0.9 | -1 | -0.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0 | -0 | -0 | -0 | Upgrade
|
| Asset Writedown | -0.02 | -0.02 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.01 | - | -0.05 | - | Upgrade
|
| Pretax Income | -0.79 | -0.9 | -0.71 | -0.9 | -1.05 | -0.85 | Upgrade
|
| Earnings From Continuing Operations | -0.79 | -0.9 | -0.71 | -0.9 | -1.05 | -0.85 | Upgrade
|
| Net Income | -0.79 | -0.9 | -0.71 | -0.9 | -1.05 | -0.85 | Upgrade
|
| Net Income to Common | -0.79 | -0.9 | -0.71 | -0.9 | -1.05 | -0.85 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 8 | 6 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 8 | 6 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 14.80% | 37.57% | 744.97% | 214.17% | 65.51% | 9.31% | Upgrade
|
| EPS (Basic) | -0.09 | -0.11 | -0.12 | -1.27 | -4.67 | -6.23 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.11 | -0.12 | -1.27 | -4.67 | -6.23 | Upgrade
|
| Free Cash Flow | -0.31 | -0.25 | -0.22 | -0.23 | -0.16 | -0.11 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.04 | -0.32 | -0.70 | -0.79 | Upgrade
|
| Gross Margin | - | - | 37.88% | 41.49% | 51.10% | 37.33% | Upgrade
|
| Operating Margin | -116060.15% | -4610.39% | -801.40% | -2456.33% | -3216.43% | -1557.70% | Upgrade
|
| Profit Margin | -116976.30% | -7097.33% | -2494.19% | -5214.08% | -5309.20% | -5189.22% | Upgrade
|
| Free Cash Flow Margin | -45369.18% | -1969.51% | -783.38% | -1323.12% | -802.24% | -654.68% | Upgrade
|
| EBITDA | -0.78 | -0.58 | -0.2 | -0.36 | -0.5 | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.03 | 0.06 | 0.13 | - | Upgrade
|
| EBIT | -0.78 | -0.58 | -0.23 | -0.42 | -0.64 | -0.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.